TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28295445

Group type: EXPERIMENTAL
Intervention: ω‐3 EFA supplements (1000 mg/day eicosapentaenoic acid + 500 mg/day docosahexaenoic acid)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (olive oil 1500 mg/day)
Number of subjects: 12
Study: 25271015

Group type: EXPERIMENTAL
Intervention: Plant stanol esters (4 g) in a high-fat shake
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control shake without plant stanol esters
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Plant stanol-enriched margarine (3 g/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control margarine
Number of subjects: 18
Study: 23496897

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention including usual care plus psychologist, occupational physician, ergonomist, case manager, and physiotherapist as RTW-coordinator.
Number of subjects: 770

Group type: COMPARATOR
Intervention: Usual care (physiotherapist, chiropractor, rheumatologist, social worker).
Number of subjects: 770
Study: 21464376

Group type: EXPERIMENTAL
Intervention: Primary care restructuring and motivational interviewing by clinicians with educational modules targeting television viewing and fast food and sugar-sweetened beverage intake.
Number of subjects: 475
Study: 18337741

Group type: EXPERIMENTAL
Intervention: Physical activity administered by the infant's mother (MOM)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Physical activity administered by a trained therapist (OT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no physical activity)
Number of subjects: 33
Study: 17065618

Group type: EXPERIMENTAL
Intervention: Daptomycin 6 mg/kg once daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Daptomycin 6 mg/kg once daily plus Gentamicin 1 mg/kg every 8 h
Number of subjects: 11
Study: 14998110

Group type: EXPERIMENTAL
Intervention: Behavioral treatment (Beh)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication management (MedMgt)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of medication and behavioral treatment (Comb)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community care (CC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Main outcome measure (composite of parent- and teacher-rated ADHD and ODD symptoms)
Number of subjects: 0
Study: 11335792

Group type: EXPERIMENTAL
Intervention: CsA 10 mg/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CsA 5 mg/kg
Number of subjects: 6
Study: 9330586

Group type: EXPERIMENTAL
Intervention: Vitamin E (15 mg/kg body weight/day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nicotinamide (25 mg/kg body weight/day)
Number of subjects: 84
Study: 7883133

Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy (SK or rtPA)
Number of subjects: 69812

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 69812
Study: 3066675

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 181
Study: 29113956

Group type: EXPERIMENTAL
Intervention: Usual care plus mailed hrHPV self-screening kits
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Usual care (annual patient reminders and ad hoc outreach by clinics)
Number of subjects: 1000
Study: 28595523

Group type: EXPERIMENTAL
Intervention: Blue-enriched white lighting (17000 K ≅ 900 lux)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Blue-enriched white lighting (17000 K)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control white lighting (4000 K ≅ 200 lux)
Number of subjects: 80
Study: 25804335

Group type: EXPERIMENTAL
Intervention: Catheter BIPFoley‐Bactiguard® (CBF)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Catheter Foley
Number of subjects: 116
Study: 23849714

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 21431354

Group type: EXPERIMENTAL
Intervention: Bioactive glass granules (BG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Autogenous bone (AB)
Number of subjects: 25
Study: 18307280

Group type: EXPERIMENTAL
Intervention: NSAID treatment (indomethacin or celebrex) for three days preoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (esomeprazole)
Number of subjects: 100
Study: 16572861

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sharp dissection
Number of subjects: 44
Study: 14763034

Group type: EXPERIMENTAL
Intervention: 3-hour exchange
Number of subjects: 9

Group type: COMPARATOR
Intervention: 8-hour exchange
Number of subjects: 9
Study: 10716466

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1,200 mg/day)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nicotinic acid (NA) (mean dose 2,250 mg/day)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combination therapy of gemfibrozil plus NA
Number of subjects: 23

Group type: COMPARATOR
Intervention: Baseline/Washout
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nicotinic acid vs. gemfibrozil
Number of subjects: 23

Group type: COMPARATOR
Intervention: Combination therapy vs. gemfibrozil alone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Combination therapy vs. NA alone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Other lipid parameters
Number of subjects: 23
Study: 9184390

Group type: EXPERIMENTAL
Intervention: Fixed minidose warfarin 1.25 mg/day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined minidose warfarin (1.25 mg/day) and aspirin (300 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conventional dose adjusted warfarin (INR 2.0-3.0)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg/day
Number of subjects: 100
Study: 8473474

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 3816922

Group type: EXPERIMENTAL
Intervention: Alinidine 40 mg p.o.
Number of subjects: 12
Study: 29366724

Group type: EXPERIMENTAL
Intervention: Community-based exercise program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 45
Study: 29300273

Group type: EXPERIMENTAL
Intervention: 90-min CPR training session
Number of subjects: 424

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 424
Study: 27653383

Group type: EXPERIMENTAL
Intervention: Web-based therapeutic education system (TES) for 12 weeks
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Web-based therapeutic education system (TES)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 507
Study: 25639140

Group type: EXPERIMENTAL
Intervention: Animal-source food supplement 5 days per week from marriage to term (approximately 13 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Animal-source food supplement 5 days per week from 16 weeks of gestation to term (approximately 5 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine prenatal care without supplemental feeding
Number of subjects: 0
Study: 23686277

Group type: EXPERIMENTAL
Intervention: Laparoscopic ileoanal pouch procedure (LAP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional ileoanal pouch procedure (CON)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both LAP and CON
Number of subjects: 42
Study: 20570472

Group type: EXPERIMENTAL
Intervention: TrapEase IVC filter
Number of subjects: 156

Group type: COMPARATOR
Intervention: Greenfield IVC filter
Number of subjects: 156
Study: 18160963

Group type: EXPERIMENTAL
Intervention: HBV‐AS04
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard hepatitis B vaccine (double doses)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Booster doses of HBV‐AS04
Number of subjects: 57
Study: 15681945

Group type: EXPERIMENTAL
Intervention: Cricoid pressure (CP)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Sham cricoid pressure (sham CP)
Number of subjects: 700
Study: 12357713

Group type: EXPERIMENTAL
Intervention: Acoustic rhinometry (AR)
Number of subjects: 10
Study: 10362454

Group type: EXPERIMENTAL
Intervention: CHO+PRO (milk protein hydrolysate supplemented drink)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CHO (same drink without protein)
Number of subjects: 0
Study: 7723156

Group type: EXPERIMENTAL
Intervention: Behavioral intervention to promote adherence to a diet providing 28% of energy from total fat, less than 8% from saturated fat, up to 9% from polyunsaturated fat, and less than 75 mg/4200 kJ (1000 kcal) per day of cholesterol (not to exceed 150 mg/d)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 663
Study: 2123987

Group type: EXPERIMENTAL
Intervention: Ultrasonography during and after radical radiotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CT scanning during and after radical radiotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasonography and CT scanning for initial tumor area measurements
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Observation of tumor calcification during and after radiotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CT number measurement of the tumor after radiotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cystoscopy within 6 months of the start of radiotherapy
Number of subjects: 50
Study: 7362505

Group type: EXPERIMENTAL
Intervention: 10% phenylephrine
Number of subjects: 150

Group type: COMPARATOR
Intervention: 1% tropicamide
Number of subjects: 150
Study: 31968573

Group type: EXPERIMENTAL
Intervention: Short-term group-based exercise (SGB) for 6 weeks followed by 18 weeks of home-based exercise
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Long-term group-based exercise (LGB) for 12 weeks followed by 18 weeks of home-based exercise
Number of subjects: 55
Study: 31342138

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1.2 g/d of elemental calcium in the form of calcium carbonate)
Number of subjects: 1368
Study: 28779963

Group type: COMPARATOR
Intervention: 40 Gy whole-breast radiotherapy (control)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: 36 Gy whole-breast radiotherapy and 40 Gy to the partial breast (reduced-dose group)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: 40 Gy to the partial breast only (partial-breast group)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Reduced-dose and partial-breast radiotherapy
Number of subjects: 2018
Study: 26116717

Group type: EXPERIMENTAL
Intervention: Telemedical monitoring
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard outpatient monitoring
Number of subjects: 401
Study: 25138182

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting balloon (DEB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 50
Study: 23033005

Group type: EXPERIMENTAL
Intervention: Capecitabine (cape) treatment with HFSR
Number of subjects: 374

Group type: COMPARATOR
Intervention: Capecitabine (cape) treatment without HFSR
Number of subjects: 374
Study: 19796562

Group type: EXPERIMENTAL
Intervention: Vitamin E gel (D-alpha-tocopheryl acetate) applied twice a week
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard ulcer care protocol only (Control)
Number of subjects: 27
Study: 18079221

Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg/d for 4 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Montelukast withdrawal
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 10745058

Group type: EXPERIMENTAL
Intervention: Testosterone (250 mg testosterone enanthate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8942440

Group type: EXPERIMENTAL
Intervention: Early versus deferred antiretroviral treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypothetical models of HIV epidemic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mathematical modeling approach
Number of subjects: 0
Study: 1561479

Group type: EXPERIMENTAL
Intervention: 200 UI/day of salmon calcitonin (CT) by nasal spray
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo by nasal spray
Number of subjects: 20
Study: 2996327

Group type: EXPERIMENTAL
Intervention: Prophylactic irradiation of the brain (3,000 rad in 10 fractions)
Number of subjects: 104

Group type: COMPARATOR
Intervention: No prophylactic irradiation of the brain
Number of subjects: 104
Study: 30880952

Group type: EXPERIMENTAL
Intervention: Lay health workers (LHWs) intervention
Number of subjects: 110
Study: 29478011

Group type: EXPERIMENTAL
Intervention: SecurAcath
Number of subjects: 105

Group type: COMPARATOR
Intervention: StatLock
Number of subjects: 105
Study: 27364372

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) group: initial arthrocentesis plus PRP injection and then four consecutive PRP injections.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) group: one session of arthrocentesis plus HA injection.
Number of subjects: 31
Study: 24246589

Group type: EXPERIMENTAL
Intervention: Accelerated care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 22460259

Group type: EXPERIMENTAL
Intervention: Ureteroscopic holmium laser lithotripsy under epidural or lumbar anesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Laparoscopic ureterolithotomy under general anesthesia
Number of subjects: 50
Study: 20650471

Group type: EXPERIMENTAL
Intervention: Oral terbutaline 2.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20% basal rate insulin reduction for 6 hours
Number of subjects: 16

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 16
Study: 18757014

Group type: EXPERIMENTAL
Intervention: Drained serums prepared by an infusion system and a three-way valve
Number of subjects: 672

Group type: COMPARATOR
Intervention: Drained serums
Number of subjects: 672
Study: 15914526

Group type: EXPERIMENTAL
Intervention: Nandrolone (150 mg IM biweekly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rhGH (6 mg SC daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12769161

Group type: EXPERIMENTAL
Intervention: Microalbuminuria at baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of microalbuminuria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE inhibitors and low-dose diuretics
Number of subjects: 0
Study: 11379860

Group type: EXPERIMENTAL
Intervention: 1.1% amino acid dialysis solution (AADS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard dialysis solutions (control)
Number of subjects: 8
Study: 15321377

Group type: EXPERIMENTAL
Intervention: SM: 0.1 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SM: 0.2 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SM: 0.1 mg plus K 60 mg i.v. one hour after spinal injection, and 30 mg i.v. every 6 h for three doses
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: K dosed as previously described (but no SM)
Number of subjects: 48

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 48
Study: 1757615

Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol propionate cream
Number of subjects: 111

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 111
Study: 29863433

Group type: EXPERIMENTAL
Intervention: Three-component module including perspective taking, education, and direct contact with gay and lesbian persons
Number of subjects: 115

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 115
Study: 30473019

Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 22
Study: 26988231

Group type: EXPERIMENTAL
Intervention: Room temperature stable carbetocin (100 μg intramuscular)
Number of subjects: 30000

Group type: COMPARATOR
Intervention: Oxytocin (10 IU intramuscular)
Number of subjects: 30000
Study: 24359507

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg/day with cognitive-behavior and motivation-enhancement therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo with cognitive-behavior and motivation-enhancement therapy
Number of subjects: 52
Study: 22480131

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (100-1600 mcg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 20574411

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal gel (0.05%)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Gel 4789 (Dapivirine vaginal gel)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Hydroxyethyl cellulose-based universal placebo gel
Number of subjects: 36
Study: 18853557

Group type: EXPERIMENTAL
Intervention: Participants who saw faces with features in the high position during the memory task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants who saw faces with features in the low position during the memory task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants who saw faces with features in the average position during the memory task
Number of subjects: 0
Study: 15868442

Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment in patients with moderate cyclin D1 expression
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: ErbB2 overexpression in patients with cyclin D1 overexpression
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Cyclin D1 expression levels (weak, moderate, strong)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: ErbB2 overexpression
Number of subjects: 230
Study: 12902960

Group type: EXPERIMENTAL
Intervention: SB Charité artificial disc replacement
Number of subjects: 60

Group type: COMPARATOR
Intervention: BAK anterior interbody fusion
Number of subjects: 60
Study: 10098360

Group type: EXPERIMENTAL
Intervention: vincristine 0.01%
Number of subjects: 20

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 20
Study: 8689817

Group type: EXPERIMENTAL
Intervention: R(+)‐terodiline hydrochloride (100 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Racemic terodiline hydrochloride (200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: S(‐)‐terodiline tartrate (100 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 1718253

Group type: EXPERIMENTAL
Intervention: Perifoveal laser photocoagulation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Untreated eyes (control)
Number of subjects: 160
Study: 6753116

Group type: EXPERIMENTAL
Intervention: Pirenzepine (100 mg/daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30925539

Group type: EXPERIMENTAL
Intervention: Awake Fiberoptic-guided intubation (FGI)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Awake McGrath videolaryngoscope-guided intubation (VGI)
Number of subjects: 46
Study: 30968542

Group type: EXPERIMENTAL
Intervention: Radiotherapy with varying extent of lymph node irradiation
Number of subjects: 330
Study: 27910185

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-eluting balloon (DEB) angioplasty
Number of subjects: 44
Study: 25352613

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (six-month physical fitness training combined with counseling sessions)
Number of subjects: 0
Study: 24402636

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg/day of zinc gluconate for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21373904

Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program
Number of subjects: 332

Group type: COMPARATOR
Intervention: Control families
Number of subjects: 332
Study: 18846551

Group type: EXPERIMENTAL
Intervention: levodopa/carbidopa/entacapone
Number of subjects: 184
Study: 17095745

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg every 8 h for 3 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 16136932

Group type: EXPERIMENTAL
Intervention: Body acupuncture
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Combined use of ear acupuncture and body acupuncture
Number of subjects: 195

Group type: COMPARATOR
Intervention: Ear acupuncture
Number of subjects: 195

Group type: COMPARATOR
Intervention: Simple body acupuncture
Number of subjects: 195
Study: 11923554

Group type: EXPERIMENTAL
Intervention: Intrapleural urokinase 40,000 units in 40 ml, administered 12 hourly for 3 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (placebo), administered 12 hourly for 3 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of urokinase and small percutaneous drain
Number of subjects: 60
Study: 9813583

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral weight-control intervention (DIET study)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Wait-listed control community
Number of subjects: 247
Study: 7658954

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) at 80% or more of 1RM, training twice weekly for 12 months.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 39
Study: 2576377

Group type: EXPERIMENTAL
Intervention: Fentanyl-nitrous oxide (Group 1)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isoflurane-fentanyl-nitrous oxide (Group 2)
Number of subjects: 19
Study: 1106447

Group type: EXPERIMENTAL
Intervention: oxazepam (30 mg) and alcohol (0.75 g/kg) combined
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: oxazepam (30 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: alcohol (0.75 g/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: alcohol given 30 min prior to oxazepam
Number of subjects: 14
Study: 31653133

Group type: EXPERIMENTAL
Intervention: Benson relaxation technique
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 29911784

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BTXA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Corticotherapy (control)
Number of subjects: 25